BioCentury
ARTICLE | Financial News

Actelion looks beyond PAH as sales top CHF2B

February 10, 2016 1:27 AM UTC

Actelion Ltd. (SIX:ATLN) reported 2015 product sales of CHF2.05 billion ($2.06 billion), crossing the CHF2 billion ($2.02 billion) threshold for the first time. Sales were up 7% at constant exchange rates from CHF1.96 billion ($1.97 billion) in 2014.

Actelion also said it expects core operating income to grow in 2016 in the low single-digit percentage range, assuming constant currency. Core EPS in 2015 was CHF6.16, up 15% at constant exchange rates from CHF5.58 in 2014. ...